About AGILeBiotics
AGILeBiotics is a company based in Groningen (Netherlands) founded in 2017 by Andreas A Bastian. AGILeBiotics operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Paratek Pharma and Antheia, among others.
- Headquarter Groningen, Netherlands
- Founders Andreas A Bastian
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AGILeBiotics
Investors in AGILeBiotics
AGILeBiotics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Carduso Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in science-driven businesses.
|
Locked | Locked | Locked |
Investor details for AGILeBiotics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AGILeBiotics
Investment portfolio details for AGILeBiotics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AGILeBiotics
Detailed financials for AGILeBiotics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Agilebiotics Comparisons
Peer comparison for AGILeBiotics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AGILeBiotics
AGILeBiotics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Paratek Pharma and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Therapeutics for antimicrobial resistant infections are developed.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
Detailed competitors of AGILeBiotics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Agilebiotics
Complete news archive for AGILeBiotics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AGILeBiotics
AGILeBiotics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
AGILeBiotics is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.
AGILeBiotics was founded in 2017 as a spin-off from the University of Groningen in the Netherlands. The company operates in the biotechnology sector, focusing on antibiotics to combat multi-drug resistant infections. A proprietary OxaSelect technology is utilized to modify existing antibiotics through site-selective processes, enabling the creation of a library of candidates derived from complex natural products that address bacterial resistance mechanisms.
AGILeBiotics's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
AGILeBiotics has 1 investor. Key investors include Carduso Capital.